PDCD1 and neoplasm: In the tumor microenvironment, the binding of programmed cell death 1 (PD‐1) and PD‐L1 has a negative‐modulating effect on T cells and reduces the production of cytokines, thereby inhibiting cytotoxic T‐cell‐mediated anti‐tumor immunity and tumor clearance ability.32, 33